These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36290098)

  • 1. Combination Regimens with Colistin Sulfate versus Colistin Sulfate Monotherapy in the Treatment of Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli.
    Hao M; Yang Y; Guo Y; Wu S; Hu F; Qin X
    Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical analysis of colistin sulfate in the treatment of pneumonia caused by carbapenem-resistant Gram-negative bacteria.
    Xu HC; Cui Y; Wang XY; Wu HB; Li W; Wang D; Lin N; Lin L; Zhang YH
    World J Clin Cases; 2024 May; 12(13):2173-2181. PubMed ID: 38808336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world data on the effects of colistin sulfate and polymyxin B sulfate in the treatment of pneumonia induced by CR-GNB.
    Liu D; Jie F; Ding Y; Qu H; Chen D; Huang J
    J Infect Dev Ctries; 2024 Jul; 18(7):1050-1057. PubMed ID: 39078788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of polymyxin B and colistin sulfate in the treatment of severe comorbid patients infected with CR-GNB.
    Wang J; Shah BK; Zhao J; Xiong J; Wang C; Xie S
    BMC Infect Dis; 2023 May; 23(1):351. PubMed ID: 37231342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and nephrotoxicity of intravenous colistin sulfate in the treatment of carbapenem-resistant gram-negative bacterial infections: a retrospective cohort study.
    Jin J; Zhu J; Zhu Z; Kim WY; O'Rourke J; Lin Z; Chen M
    Ann Transl Med; 2022 Oct; 10(20):1137. PubMed ID: 36388829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of colistin sulfate in the treatment of infections caused by carbapenem-resistant organisms: a multicenter retrospective cohort study.
    Peng D; Zhang F; Chen Y; Zhao C; Niu J; Yang J; Li Z; Chen C; Qiu S; Zhang H; Qin B; Fang X; Guo S; Liu Y; Shao H
    J Thorac Dis; 2023 Apr; 15(4):1794-1804. PubMed ID: 37197520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Efficacy and Safety of Colistin Sulfate in the Treatment of Carbapenem-Resistant Organism Infections in Patients with Hematological Diseases.
    Wu Y; Jiang S; Li D; Wu Y; Li Q; Wang X; Liu B; Bao H; Wu D; Hu X
    Infect Dis Ther; 2024 Jan; 13(1):141-154. PubMed ID: 38212555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of adjunctive nebulized colistin sulfate for multidrug-resistant Gram-negative bacteria pneumonia: a retrospective comparative cohort study.
    Bao XL; Tao T; Tang N; Wang YZ; Liao XQ; Huang LL; Ji JJ; Chen X
    Ann Palliat Med; 2022 Sep; 11(9):2939-2951. PubMed ID: 36217623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical Analysis of Colistin Sulfate in the Treatment of Hematonosis Infected by Multidrug-Resistant Gram-Negative Bacteria].
    Wu YB; Jiang SS; Wu YX; Li DY; Li Q; Wang X; Liu B; Bao HY; Hu XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1878-1884. PubMed ID: 38071076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital.
    Shah PG; Shah SR
    J Assoc Physicians India; 2015 Jul; 63(7):14-8. PubMed ID: 26731822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous Colistin Monotherapy versus Combination Therapy against Carbapenem-Resistant Gram-Negative Bacteria Infections: Meta-Analysis of Randomized Controlled Trials.
    Cheng IL; Chen YH; Lai CC; Tang HJ
    J Clin Med; 2018 Aug; 7(8):. PubMed ID: 30103414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyxin Monotherapy vs. Combination Therapy for the Treatment of Multidrug-resistant Infections: A Systematic Review and Meta-analysis.
    Samal S; Samir SB; Patra SK; Rath A; Dash A; Nayak B; Mohanty D
    Indian J Crit Care Med; 2021 Feb; 25(2):199-206. PubMed ID: 33707900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
    Scudeller L; Righi E; Chiamenti M; Bragantini D; Menchinelli G; Cattaneo P; Giske CG; Lodise T; Sanguinetti M; Piddock LJV; Franceschi F; Ellis S; Carrara E; Savoldi A; Tacconelli E
    Int J Antimicrob Agents; 2021 May; 57(5):106344. PubMed ID: 33857539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a prognostic nomogram to predict 30-day all-cause mortality in patients with CRO infection treated with colistin sulfate.
    Li W; Liu Y; Xiao L; Cai X; Gao W; Xu D; Han S; He Y
    Front Pharmacol; 2024; 15():1409998. PubMed ID: 39101134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study.
    Wu Z; Zhang S; Cao Y; Wang Q; Sun K; Zheng X
    Front Pharmacol; 2023; 14():1209063. PubMed ID: 37663252
    [No Abstract]   [Full Text] [Related]  

  • 16. Colistin monotherapy versus colistin-based combination therapy for treatment of bacteremia in burn patients due to carbapenem-resistant gram negative bacteria.
    Park JJ; Seo YB; Lee J; Choi YK; Jeon J
    Burns; 2020 Dec; 46(8):1848-1856. PubMed ID: 32622621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant
    Sirijatuphat R; Thawornkaew S; Ruangkriengsin D; Thamlikitkul V
    Antibiotics (Basel); 2022 Nov; 11(12):. PubMed ID: 36551364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatments and Predictors of Mortality for Carbapenem-Resistant Gram-Negative Bacilli Infections in Malaysia: A Retrospective Cohort Study.
    Abubakar U; Zulkarnain AI; Rodríguez-Baño J; Kamarudin N; Elrggal ME; Elnaem MH; Harun SN
    Trop Med Infect Dis; 2022 Dec; 7(12):. PubMed ID: 36548670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis.
    Zusman O; Altunin S; Koppel F; Dishon Benattar Y; Gedik H; Paul M
    J Antimicrob Chemother; 2017 Jan; 72(1):29-39. PubMed ID: 27624572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.
    Paul M; Daikos GL; Durante-Mangoni E; Yahav D; Carmeli Y; Benattar YD; Skiada A; Andini R; Eliakim-Raz N; Nutman A; Zusman O; Antoniadou A; Pafundi PC; Adler A; Dickstein Y; Pavleas I; Zampino R; Daitch V; Bitterman R; Zayyad H; Koppel F; Levi I; Babich T; Friberg LE; Mouton JW; Theuretzbacher U; Leibovici L
    Lancet Infect Dis; 2018 Apr; 18(4):391-400. PubMed ID: 29456043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.